newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update

- Received FDA Clearance of IND Application for DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin-Related Hearing Loss - - Announced Submission of CTAs for DB-OTO in the